Provided by Tiger Trade Technology Pte. Ltd.

OCUMENSION-B

5.285
-0.030-0.56%
Volume:64.00K
Turnover:338.62K
Market Cap:4.31B
PE:-22.65
High:5.340
Open:5.320
Low:5.270
Close:5.315
52wk High:12.070
52wk Low:4.040
Shares:815.00M
HK Float Shares:815.00M
Volume Ratio:0.18
T/O Rate:0.01%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.233
ROE:-4.26%
ROA:-2.48%
PB:1.00
PE(LYR):-22.65
PS:4.59

Loading ...

ASCLETIS-B Shares Surge Over 4% in Morning Session as Key Pipeline Drug ASC30 Nears Phase III Trial

Stock News
·
Apr 24

Roche CEO Comments on Strong Swiss Franc, Boosts US Investment

Deep News
·
Apr 23

AbbVie Commits $1.4 Billion to Establish New Pharmaceutical Campus in North Carolina

Deep News
·
Apr 23

Pharma's "SpaceX" Sets Sail: The First AI-Driven Drug Delivery Pioneer, Jitai Tech Ushers in the Era of Biologics Delivery

Stock News
·
Apr 20

Insilico Medicine Surges Over 6% on AI-Driven Drug Discovery Advancements and Strategic Partnership

Stock News
·
Apr 20

ASCLETIS-B Nears Previous Peak, But Why Are Investors Staying on the Sidelines?

Stock News
·
Apr 18

ASCLETIS-B Shares Surge Nearly 5% in Afternoon Trading, Approaching All-Time High as GLP-1 and Amylin Combo Enters Clinical Trials

Stock News
·
Apr 17

CXO Concept Stocks Lead Declines in Hong Kong Market as Overseas Investment Environment Enters Volatile Phase

Stock News
·
Apr 17

Appeal Hearing Concludes for Hainan Poly Pharm Investor Compensation Case, Beijing Tongtech Claim Filed Again

Deep News
·
Apr 17

Hetero Pharma Aims for Global Sales Target of 1.5 Million Semaglutide Pens Annually

Deep News
·
Apr 16

Foreign Enterprise in Shanghai Donates 190 Boxes of Supplies to Support Seniors and Children

Deep News
·
Apr 16

AI-Powered Drug Development Enters Rapid Growth Phase, Transitioning from Proof-of-Concept to Commercialization

Stock News
·
Apr 13

Ocumension Therapeutics Reports No Share Capital Changes for March 2026; Option Activity Limited

Bulletin Express
·
Apr 08

Key Information Missing from Hanfang Pharmaceutical's Hong Kong IPO Prospectus

Deep News
·
Apr 08

ASCLETIS-B Advances Clinical Development of Fixed-Dose Combination ASC30_39 for Obesity Treatment

Stock News
·
Apr 07

Shanghai Stock Exchange Approves Tainuo Maibo's IPO Application

Deep News
·
Apr 03

Chemical Pharmaceutical Sector Performance Overview: Divergence Between Formulations and APIs, Innovative Drugmakers Stand Out

Deep News
·
Apr 03

Pharmaceutical Sector Defies Market Downturn with Strong Resilience

Deep News
·
Apr 02

Stock Track | OCUMENSION-B Soars 5.10% Intraday on Positive Analyst Rating

Stock Track
·
Apr 02

Revised title

Stock News
·
Apr 02